RICHMOND, Va. — Haleon, a global company behind home healthcare products like Advil, Tums and Aquafresh, announced Monday its plan to upgrade its Richmond research and development facility.

Haleon, an international manufacturer of medicine, vitamins and toothpaste, will upgrade its lab in Richmond's North Side at a cost of $54 million, the company announced Monday. Based in England ...

The UK-based pharmaceutical company Haleon will invest $54.2 million to upgrade its R&D facility in Richmond, which has helped birth or grow products such as Advil, Emergen-C and Robitussin.

Haleon, a global consumer health company, is investing $54.2 million to upgrade its research & development (R&D) facility in Richmond, Virginia. The modernization will enable the company to expand ...

Seguidamente, se encuentra Haleon, empresa comerciante de marcas como Paradontax y Voltaren con un total de 6,6 millones de euros invertidos este año. La tercera posición la ocupa Bayer, con 6,5 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Once complete, Pfizer's stake in Haleon will fall from 15.0% to around 7.3%. Pfizer's move comes after Haleon's spin-off as an independent consumer healthcare company, part of plans to reshape its ...

In an interview with Gulf Business, Charles Leslie, global business lead for the Pain Portfolio & Systemics at Haleon, outlines key consumer health trends reshaping the healthcare sector ...

Pfizer (PFE) announces that it intends to sell approximately 700M ordinary shares in Haleon plc (HLN), representing approximately 7.7% of Haleon’s issued share capital. “There will be no sale ...

(RTTNews) - Pfizer Inc. (PFE) Wednesday announced the sale of 700 million shares in Haleon Plc (HLN), a British multinational consumer healthcare company, at 357 pence per share or approximately $ ...